Marina Biotech (MRNA) Posts Wider than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Join SI Premium – FREE
Marina Biotech, Inc. (Nasdaq: MRNA) reported Q1 loss of ($0.12), $0.01 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $214 million versus the consensus estimate of $150 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
